Implementation of a care bundle improves PBC management
Rachel Smith,
Laura Burke,
Nadir Abbas,
Richard J. Aspinall,
Douglas Thorburn,
Michael Heneghan,
Andrew Yeoman,
Joanna Leithead,
Conor Braniff,
Robert Mitchell-Thain,
Rebecca L. Jones,
Stuart McPherson,
Jessica K. Dyson,
David Jones,
Palak J. Trivedi,
Laith Alrubaiy,
George F. Mells
Affiliations
Rachel Smith
Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Laura Burke
Department of Hepatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Nadir Abbas
NIHR Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research, University of Birmingham, Birmingham, UK; Liver Unit, University Hospitals Birmingham Queen Elizabeth, Birmingham, UK; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Richard J. Aspinall
Department of Gastroenterology and Hepatology, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK
Douglas Thorburn
Department of Hepatology and Liver Transplantation, Royal Free Hospital NHS Foundation Trust, London, UK
Michael Heneghan
Institute of Liver Studies, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Andrew Yeoman
Aneurin Bevan University Health Board, Newport, UK
Joanna Leithead
Department of Hepatology, Forth Valley Royal Hospital, Larbert, UK
Conor Braniff
Department of Hepatology, Regional Liver Unit, Belfast Health and Social Care Trust, Belfast, UK
Robert Mitchell-Thain
PBC Foundation, Edinburgh, UK
Rebecca L. Jones
Department of Hepatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Stuart McPherson
Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle, UK
Jessica K. Dyson
Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle, UK
David Jones
Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle, UK
Palak J. Trivedi
NIHR Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research, University of Birmingham, Birmingham, UK; Liver Unit, University Hospitals Birmingham Queen Elizabeth, Birmingham, UK; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Institute of Applied Health Research, University of Birmingham, Birmingham, UK
Laith Alrubaiy
Department of Gastroenterology, St Mark’s Hospital and Academic Institute, London, UK; Swansea University Medical School, Swansea, UK
George F. Mells
Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle, UK; Population Health Sciences Institute, Newcastle University, Newcastle, UK; Corresponding author. Address: Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Background & Aims: In 2021, we conducted a UK-wide audit of the management of primary biliary cholangitis (PBC) in the National Health Service (NHS) of the UK, which identified widespread deficiencies in PBC-related healthcare. In the current study, recognising the need to address these deficiencies, we aimed to (1) develop a PBC care bundle to support clinicians in the provision of high-quality, standardised care; (2) pilot the bundle in selected centres across the UK; and (3) re-evaluate adherence to quality standards. Methods: We designed a PBC care bundle that incorporated a checklist of quality standards and a summary of guidelines from the British Society of Gastroenterology. Twelve hospitals, with variable performance in the national audit, were invited to pilot the bundle between 1 October 2023 and 31 March 2024. Clinical data were collected to compare adherence to quality standards before and after bundle use. Results: We obtained data about 773 patients with PBC. We found significant improvement in performance across all quality standards following bundle use, with two hospitals achieving target performance (≥90%) across all standards, something not achieved by any hospital in the national audit. Across all centres, referral of patients for second-line therapy increased from 72% to 94% (p <0.001). Assessment of symptoms improved from 54% to 90% (p <0.001), and bone health improved from 65% to 86% (p <0.001). Surveillance for hepatocellular carcinoma increased from 67% to 97% (p <0.001), and screening for gastro-oesophageal varices improved from 81% to 92% (p = 0.027). Conclusions: Use of the PBC care bundle significantly improves adherence to management guidelines. Rollout of the bundle will mark a vital step to improve the delivery of high-quality care to all patients with PBC. Impact and implications: The national primary biliary cholangitis (PBC) audit demonstrated critical shortfalls in the delivery of PBC-related healthcare across the UK. In this study, we have designed a PBC care bundle to improve adherence to management guidelines and promote standardised care. We show that use of the bundle improves care delivery in hospitals across the NHS. The PBC care bundle has been endorsed by the British Society of Gastroenterology and the British Association for the Study of the Liver and is freely available online to all clinicians to support the provision of high-quality PBC-related healthcare.